ArticleFrontiers in pharmacology2021

Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World Studies.

Jun Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.